---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-195360"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T01:42:01.242418+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q2 2023 revenue $15.86B; EPS $4.29; raises 2023 guidance

## Summary
- Revenue $15.861B, up 7% YoY; net income $1.193B, diluted EPS $4.29 (vs $3.90).
- Adjusted EBITDA $3.056B; same facility admissions +2.2%, equivalent admissions +3.7%.
- 2023 guidance raised: revenue $63.25-$64.75B, EPS $17.70-$18.90.
- Quarterly dividend $0.60/share, payable Sept 29 to holders of record Sept 15.
- Repurchased 3.3M shares for $915M in Q2; $2.825B remaining authorization.

## SEC filing metadata
- accession: 0001193125-23-195360
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/0001193125-23-195360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/d536904d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-195360
- JSON: https://secwatch.observer/filing/0001193125-23-195360.json
- Plain text: https://secwatch.observer/filing/0001193125-23-195360.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.